P16.01 Surgery for recurrent high grade glioma after treatment with bevacizumab

Por Blumenthal, D. T., Bokstein, F.
Publicado no Neuro Oncol (2017)

Painful paroxysmal dystonia associated with focal epileptic activity.

Por Bokstein, F, Neufeld, M Y, Nisipeanu, P, Korczyn, A D
Publicado em 1995

P01.028 Tumor treating fields and radiotherapy for newly diagnosed glioblastoma: Safety results from a pilot study

Por Grossman, R, Bokstein, F, Ben Harosh, C, Blumenthal, D, Limon, D, Ram, Z
Publicado no Neuro Oncol (2018)

Zoster sine herpete: Virologic verification by detection of anti-VZV IgG antibody in CSF

Por Blumenthal, D.T., Shacham-Shmueli, E., Bokstein, F., Schmid, D.S., Cohrs, R.J., Nagel, M.A., Mahalingam, R., Gilden, D.
Publicado em 2011

P01.076 Experience with tumor treating fields (TTFields, Optune®) in Israel - patient compliance and adverse effects

Por Siegal, T, Bokstein, F, Blumenthal, D T, Zach, L, Leibovici, A, Yust-Katz, S, Lossos, A, Tzuk-Shina, T, Lokiec, A, Ram, Z
Publicado no Neuro Oncol (2018)

P06.14 Early biomarkers from conventional MRI and TRAMs for predicting response to bevacizumab in recurrent high-grade gliomas

Por Daniels, D., Guez, D., Last, D., Talianski, A., Kanner, A. A., Blumenthal, D. T., Bokstein, F., Cohen, Z. R., Mardor, Y., Zach, L.
Publicado no Neuro Oncol (2016)